Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025

Yujing Liang, Xinyi Deng, Ziwen Wang, Chuanmiao Xie, Lie Zheng, He Huang, Shaohan Yin, Huageng Huang

Open source

DOI: 10.1186/s40164-026-00821-0
Published: 2026-08-28
Container: Experimental Hematology & Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40164-026-00821-0,
  title = {Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025},
  author = {Yujing Liang and Xinyi Deng and Ziwen Wang and Chuanmiao Xie and Lie Zheng and He Huang and Shaohan Yin and Huageng Huang},
  year = {2026},
  journal = {Experimental Hematology \&amp; Oncology},
  doi = {10.1186/s40164-026-00821-0},
  url = {https://doi.org/10.1186/s40164-026-00821-0}
}

RIS

TY  - JOUR
TI  - Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025
AU  - Yujing Liang
AU  - Xinyi Deng
AU  - Ziwen Wang
AU  - Chuanmiao Xie
AU  - Lie Zheng
AU  - He Huang
AU  - Shaohan Yin
AU  - Huageng Huang
PY  - 2026
JO  - Experimental Hematology &amp; Oncology
DO  - 10.1186/s40164-026-00821-0
UR  - https://doi.org/10.1186/s40164-026-00821-0
ER  -

APA

Liang, Y., Deng, X., Wang, Z., Xie, C., Zheng, L., Huang, H., Yin, S., & Huang, H. (2026). Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-026-00821-0

Source records

crossref · retrieved 2026-09-25T17:58:34.378Z